NASDAQ:CHEK Check-Cap (CHEK) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CHEK Stock Alerts $2.75 +0.28 (+11.34%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$2.24▼$2.8450-Day Range$1.87▼$2.7552-Week Range$1.25▼$4.63Volume663,914 shsAverage Volume694,738 shsMarket Capitalization$16.09 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Check-Cap alerts: Email Address Check-Cap MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside154.5% Upside$7.00 Price TargetShort InterestHealthy0.78% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.54) to ($1.63) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.83 out of 5 starsMedical Sector639th out of 939 stocksX-Ray Apparatus & Tubes Industry3rd out of 3 stocks 3.0 Analyst's Opinion Consensus RatingCheck-Cap has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.00, Check-Cap has a forecasted upside of 154.5% from its current price of $2.75.Amount of Analyst CoverageCheck-Cap has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.78% of the float of Check-Cap has been sold short.Short Interest Ratio / Days to CoverCheck-Cap has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Check-Cap has recently increased by 185.92%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCheck-Cap does not currently pay a dividend.Dividend GrowthCheck-Cap does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CHEK. Previous Next 3.0 News and Social Media Coverage News SentimentCheck-Cap has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Check-Cap this week, compared to 1 article on an average week.Search Interest1 people have searched for CHEK on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Check-Cap to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Check-Cap insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.48% of the stock of Check-Cap is held by insiders.Percentage Held by InstitutionsOnly 1.07% of the stock of Check-Cap is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Check-Cap are expected to grow in the coming year, from ($2.54) to ($1.63) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Check-Cap is -0.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Check-Cap is -0.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCheck-Cap has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTICBOE shift unlocks new weekend income strategyYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! About Check-Cap Stock (NASDAQ:CHEK)Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Read More CHEK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEK Stock News HeadlinesMarch 28, 2024 | americanbankingnews.comCheck-Cap (CHEK) Scheduled to Post Earnings on FridayMarch 26, 2024 | msn.comAI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-CapMarch 28, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.March 26, 2024 | investorplace.comWhy Is Check-Cap (CHEK) Stock Up 44% Today?March 25, 2024 | prnewswire.comNobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination AgreementMarch 22, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Check-Cap (NASDAQ:CHEK)March 19, 2024 | msn.comWhat the Chargers can do with their cap space after roster movesMarch 8, 2024 | msn.comHow much cap space do the Seahawks have after trio of Tuesday cuts?March 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 24, 2024 | jaguarswire.usatoday.comLarger than expected salary cap means more space for JaguarsFebruary 23, 2024 | msn.comBengals emerge big winners with updated cap space after 2024 cap revealFebruary 10, 2024 | investing.comCheck Cap Ltd (CHEK)December 22, 2023 | finance.yahoo.comSYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTDDecember 14, 2023 | finance.yahoo.comCheck-Cap Board of Directors Issues Letter to ShareholdersDecember 8, 2023 | finance.yahoo.comCITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEESDecember 7, 2023 | finance.yahoo.comLeading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination AgreementDecember 5, 2023 | finance.yahoo.comCHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEESNovember 29, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Earnings Dates and Earning CallsNovember 28, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Dividends: History, Yield and DatesNovember 27, 2023 | benzinga.comCheck-Cap: Q3 Earnings InsightsNovember 27, 2023 | msn.comCheck-Cap GAAP EPS of -$0.44November 27, 2023 | markets.businessinsider.comCheck-Cap Posts Narrower Loss In Q3 - Quick FactsNovember 27, 2023 | finance.yahoo.comCheck-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate UpdateNovember 7, 2023 | morningstar.comCheck-Cap Ltd CHEKOctober 31, 2023 | markets.businessinsider.comNotice of Extraordinary General Meeting of ShareholdersOctober 27, 2023 | msn.comCheck out some of the caps you can get at a Bucks game this yearOctober 26, 2023 | bloomberg.comKazakhstan Aims to Cut Loan-Rate CapSee More Headlines Receive CHEK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/27/2023Today3/28/2024Next Earnings (Estimated)3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry X-ray apparatus & tubes Sub-IndustryN/A Current SymbolNASDAQ:CHEK CUSIPN/A CIK1610590 Webwww.check-cap.com Phone972546706451Fax972-4821-1267Employees85Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+154.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($3.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-47.85% Return on Assets-43.50% Debt Debt-to-Equity RatioN/A Current Ratio17.60 Quick Ratio17.60 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$8.57 per share Price / Book0.32Miscellaneous Outstanding Shares5,850,000Free Float5,822,000Market Cap$16.09 million OptionableNot Optionable Beta0.21 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Alex Ovadia (Age 62)CEO & Director Comp: $409.35kDr. Yoav Kimchy Ph.D. (Age 63)Founder & Chief Technology Officer Comp: $362.65kMs. Mira Rosenzweig (Age 52)Chief Financial Officer Comp: $287.99kMr. Joshua Belkar (Age 55)Vice President of Operations Comp: $269.57kMs. Noa Reshef M.B.A.Director of Human ResourcesKey CompetitorsRedHill BiopharmaNASDAQ:RDHLSyra HealthNASDAQ:SYRAInhibikase TherapeuticsNYSE:IKTAccelerate DiagnosticsNASDAQ:AXDXBiomericaNASDAQ:BMRAView All CompetitorsInstitutional OwnershipNantahala Capital Management LLCBought 33,400 shares on 2/15/2024Ownership: 0.000%Dimensional Fund Advisors LPBought 14,898 shares on 2/7/2024Ownership: 0.000%View All Institutional Transactions CHEK Stock Analysis - Frequently Asked Questions Should I buy or sell Check-Cap stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares. View CHEK analyst ratings or view top-rated stocks. What is Check-Cap's stock price target for 2024? 1 equities research analysts have issued 1 year price objectives for Check-Cap's stock. Their CHEK share price targets range from $7.00 to $7.00. On average, they predict the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 154.5% from the stock's current price. View analysts price targets for CHEK or view top-rated stocks among Wall Street analysts. How have CHEK shares performed in 2024? Check-Cap's stock was trading at $2.08 on January 1st, 2024. Since then, CHEK shares have increased by 32.2% and is now trading at $2.75. View the best growth stocks for 2024 here. Are investors shorting Check-Cap? Check-Cap saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 40,600 shares, an increase of 185.9% from the February 29th total of 14,200 shares. Based on an average daily volume of 228,100 shares, the short-interest ratio is presently 0.2 days. Currently, 0.8% of the company's shares are short sold. View Check-Cap's Short Interest. When is Check-Cap's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our CHEK earnings forecast. How were Check-Cap's earnings last quarter? Check-Cap Ltd. (NASDAQ:CHEK) announced its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, beating the consensus estimate of ($0.83) by $0.39. When did Check-Cap's stock split? Check-Cap shares reverse split on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Check-Cap own? Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Acasti Pharma (ACST), Avinger (AVGR), Biocept (BIOC) and Purple Biotech (KTOV). When did Check-Cap IPO? Check-Cap (CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager. Who are Check-Cap's major shareholders? Check-Cap's stock is owned by a variety of institutional and retail investors. Top institutional investors include Nantahala Capital Management LLC (0.00%) and Dimensional Fund Advisors LP (0.00%). How do I buy shares of Check-Cap? Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CHEK) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.